Literature DB >> 25752543

Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form.

Matthew W Parker1, Andrew D Linkugel2, Hira Lal Goel3, Tingting Wu1, Arthur M Mercurio3, Craig W Vander Kooi4.   

Abstract

Vascular endothelial growth factor C (VEGF-C) is a potent lymphangiogenic cytokine that signals via the coordinated action of two cell surface receptors, Neuropilin-2 (Nrp2) and VEGFR-3. Diseases associated with both loss and gain of VEGF-C function, lymphedema and cancer, respectively, motivate studies of VEGF-C/Nrp2 binding and inhibition. Here, we demonstrate that VEGF-C binding to Nrp2 is regulated by C-terminal proteolytic maturation. The structure of the VEGF-C C terminus in complex with the ligand binding domains of Nrp2 demonstrates that a cryptic Nrp2 binding motif is released upon proteolysis, allowing specific engagement with the b1 domain of Nrp2. Based on the identified structural requirements for Nrp2 binding to VEGF-C, we hypothesized that the endogenous secreted splice form of Nrp2, s9Nrp2, may function as a selective inhibitor of VEGF-C. We find that s9Nrp2 forms a stable dimer that potently inhibits VEGF-C/Nrp2 binding and cellular signaling. These data provide critical insight into VEGF-C/Nrp2 binding and inhibition.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25752543      PMCID: PMC4394031          DOI: 10.1016/j.str.2015.01.018

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  67 in total

1.  Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity.

Authors:  M L Gagnon; D R Bielenberg; Z Gechtman; H Q Miao; S Takashima; S Soker; M Klagsbrun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia.

Authors:  A Lymboussaki; B Olofsson; U Eriksson; K Alitalo
Journal:  Circ Res       Date:  1999-11-26       Impact factor: 17.367

3.  Coordinated regulation of polycomb group complexes through microRNAs in cancer.

Authors:  Qi Cao; Ram-Shankar Mani; Bushra Ateeq; Saravana M Dhanasekaran; Irfan A Asangani; John R Prensner; Jung H Kim; J Chad Brenner; Xiaojun Jing; Xuhong Cao; Rui Wang; Yong Li; Arun Dahiya; Lei Wang; Mithil Pandhi; Robert J Lonigro; Yi-Mi Wu; Scott A Tomlins; Nallasivam Palanisamy; Zhaohui Qin; Jindan Yu; Christopher A Maher; Sooryanarayana Varambally; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2011-08-16       Impact factor: 31.743

4.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

5.  VEGF-Trap: a VEGF blocker with potent antitumor effects.

Authors:  Jocelyn Holash; Sam Davis; Nick Papadopoulos; Susan D Croll; Lillian Ho; Michelle Russell; Patricia Boland; Ray Leidich; Donna Hylton; Elena Burova; Ella Ioffe; Tammy Huang; Czeslaw Radziejewski; Kevin Bailey; James P Fandl; Tom Daly; Stanley J Wiegand; George D Yancopoulos; John S Rudge
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.

Authors:  S Soker; H Fidder; G Neufeld; M Klagsbrun
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

Review 8.  Function of members of the neuropilin family as essential pleiotropic cell surface receptors.

Authors:  Matthew W Parker; Hou-Fu Guo; Xiaobo Li; Andrew D Linkugel; Craig W Vander Kooi
Journal:  Biochemistry       Date:  2012-11-14       Impact factor: 3.162

9.  VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.

Authors:  E Kukk; A Lymboussaki; S Taira; A Kaipainen; M Jeltsch; V Joukov; K Alitalo
Journal:  Development       Date:  1996-12       Impact factor: 6.868

Review 10.  The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease.

Authors:  David I R Holmes; Ian Zachary
Journal:  Genome Biol       Date:  2005-02-01       Impact factor: 13.583

View more
  22 in total

Review 1.  Neuropilin Functions as an Essential Cell Surface Receptor.

Authors:  Hou-Fu Guo; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

2.  NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry.

Authors:  Matthijs Raaben; Lucas T Jae; Andrew S Herbert; Ana I Kuehne; Sarah H Stubbs; Yi-Ying Chou; Vincent A Blomen; Tomas Kirchhausen; John M Dye; Thijn R Brummelkamp; Sean P Whelan
Journal:  Cell Host Microbe       Date:  2017-11-08       Impact factor: 21.023

3.  Neuropilin-2 regulates airway inflammatory responses to inhaled lipopolysaccharide.

Authors:  Robert M Immormino; David C Lauzier; Hideki Nakano; Michelle L Hernandez; Neil E Alexis; Andrew J Ghio; Stephen L Tilley; Claire M Doerschuk; David B Peden; Donald N Cook; Timothy P Moran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-04-19       Impact factor: 5.464

4.  Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer.

Authors:  Samikshan Dutta; Navatha Shree Polavaram; Ridwan Islam; Sreyashi Bhattacharya; Sanika Bodas; Thomas Mayr; Sohini Roy; Sophie Alvarez Y Albala; Marieta I Toma; Anza Darehshouri; Angelika Borkowetz; Stefanie Conrad; Susanne Fuessel; Manfred Wirth; Gustavo B Baretton; Lorenz C Hofbauer; Paramita Ghosh; Kenneth J Pienta; David L Klinkebiel; Surinder K Batra; Michael H Muders; Kaustubh Datta
Journal:  Oncogene       Date:  2022-06-27       Impact factor: 8.756

Review 5.  Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance.

Authors:  Ridwan Islam; Juhi Mishra; Sanika Bodas; Sreyashi Bhattacharya; Surinder K Batra; Samikshan Dutta; Kaustubh Datta
Journal:  Cancer Metastasis Rev       Date:  2022-07-01       Impact factor: 9.237

6.  Design, synthesis, and evaluation of a novel benzamidine-based inhibitor of VEGF-C binding to Neuropilin-2.

Authors:  Ahmed M Said; Matthew W Parker; Craig W Vander Kooi
Journal:  Bioorg Chem       Date:  2020-04-16       Impact factor: 5.307

Review 7.  TGF-β superfamily co-receptors in cancer.

Authors:  John B Pawlak; Gerard C Blobe
Journal:  Dev Dyn       Date:  2021-04-09       Impact factor: 3.780

8.  Solubility and Aggregation of Selected Proteins Interpreted on the Basis of Hydrophobicity Distribution.

Authors:  Magdalena Ptak-Kaczor; Mateusz Banach; Katarzyna Stapor; Piotr Fabian; Leszek Konieczny; Irena Roterman
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

Review 9.  Peripheral vascular disease: preclinical models and emerging therapeutic targeting of the vascular endothelial growth factor ligand-receptor system.

Authors:  Vijay Chaitanya Ganta; Brian H Annex
Journal:  Expert Opin Ther Targets       Date:  2021-06-17       Impact factor: 6.797

10.  Structural studies of neuropilin-2 reveal a zinc ion binding site remote from the vascular endothelial growth factor binding pocket.

Authors:  Yi-Chun Isabella Tsai; Constantina Fotinou; Rohini Rana; Tamas Yelland; Paul Frankel; Ian Zachary; Snezana Djordjevic
Journal:  FEBS J       Date:  2016-04-01       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.